European Union Takes First Step To Enlargement

17 December 1997

The European Union has taken its first major step towards opening itsborders and institutions to the new democracies of Central and Eastern Europe (the CEECs). Once complete, the enlarged EU will form a single market, which will stretch from the Atlantic Ocean to the Black Sea, and comprise nearly 500 million citizens - and consumers.

Monetary Union Now Looks Unstoppable Within this free-trade zone, and by the time enlargement finally occurs, EU consumers will most likely be buying goods and services with a single currency, the Euro, throughout Europe. The EU's vision for economic and monetary union (EMU) now looks unstoppable.

According to the results of the December EU summit (in Luxembourg), talks will begin on enlargement with all 11 candidate member countries at the end of March 1998. However, actual talks will resume with only six of the candidate countries, and these will start in April. The first six countries are the Czech Republic, Hungary, Poland, Slovenia, Estonia, and Cyprus.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight